WHO Proposes New Mode Of Engaging With Non-State Actors 28/01/2021 Esther Nakkazi The World Health Organization (WHO) aims to make its engagement with non-state actors (non-state actors) more meaningful and efficient with a new proposal to establish a number of NSA fora that would allow exchange with WHO and member state representatives outside of official meetings. The new proposal — which will be tested during the 74th […] Continue reading -> Important Advances in HIV Prevention Unveiled: New PrEP Formulas & Broadly Neutralizing Antibodies 27/01/2021 Paul Adepoju & Svĕt Lustig Vijay While global attention has fixated on the coronavirus, the forty-year long fight against HIV, which has claimed 33 million lives, is seeing new breakthroughs in preventive tools. New discoveries of “broadly neutralizing antibodies” as well as novel regimens of pre-exposure prophylaxis (PrEP), could strengthen the world’s toolbox to prevent the disease, announced the International AIDS […] Continue reading -> European Countries Start Recommending High-Filtration Masks – Over ‘Artisanal’ Cloth Variants 27/01/2021 Madeleine Hoecklin In the midst of the spread of new SARS-CoV2 virus variants, several European countries have updated their guidance and regulations on masks, to recommend the use of high-filtration medical-grade masks over fabric ones in confined settings. France’s health advisory council (Haute Conseil de la Santé Publique) issued new recommendations last week, warning against the wearing […] Continue reading -> Low-Income Countries Can Expect Higher Mortality From ‘Collateral Damage’ Than COVID-19, Global Fund Head Predicts 26/01/2021 J Hacker While very low-income countries have experienced relatively low mortality rates from COVID-19, they can expect higher mortality caused by the knock-on effects of the pandemic on their fragile health systems, according to the Executive Director of the Global Fund to Fight AIDS, TB and Malaria. Since the pandemic first overwhelmed health systems in early 2020, […] Continue reading -> Moderna’s COVID-19 Vaccine ‘Safe’ For Most People WHO Experts Say – But No Recommendation For Pregnant Women Or Children 26/01/2021 J Hacker The Moderna COVID-19 vaccine is safe for most people including those with a wide range of underlying medical conditions, according to the World Health Organization’s Strategic Advisory Group of Experts (SAGE) on immunizations. However, the vaccine is not recommended for pregnant women or children as it has not been tested on these groups, according to […] Continue reading -> COVAX Planning Per-Dose Vaccine Levy To Fund Compensation Scheme 26/01/2021 Kerry Cullinan The global COVID-19 vaccine access platform, COVAX, plans to impose a US 10-cent levy on each vaccine dose to fund a compensation scheme for people who suffer from severe adverse reactions to any of the vaccines it supplies. The “no-fault” compensation fund is crucial for countries who join COVAX, as one of the conditions of […] Continue reading -> Member States Raise Concerns About Sustainability Of Funding For Polio & Antimicrobial Resistance Efforts 26/01/2021 Madeleine Hoecklin COVID-19 has led to the suspension of polio campaigns in more than 30 countries, and has underscored the importance of the mission to eradicate it, tackle antimicrobial resistance, and ensure the timely sharing of pathogens, said WHO member states at Monday’s Executive Board session. Throughout the morning and afternoon sessions, member states reviewed and discussed […] Continue reading -> Interview with Björn Kümmel, Vice Chair, WHO Executive Board 26/01/2021 Priti Patnaik Discussions on WHO’s state of financing were addressed by member states during the on-going Executive Board meeting. As we reported last week, WHO is keen on defining independence and sustainability of its financing to be better prepared to address emergencies in the future. We spoke to Björn Kümmel, Deputy Head of Unit, Global Health, German Federal Ministry […] Continue reading -> UK COVID-19 Variant: US Official ‘Convinced’ Of Increased Mortality Despite ‘Uncertain’ Evidence 25/01/2021 J Hacker Michael Osterholm – a leading member of the United States President’s coronavirus transition team – has said he is “convinced” by data indicating the UK COVID-19 variant is more deadly, even as United Kingdom officials downplay the limited and “uncertain” evidence. Meanwhile, Moderna announced today that it will “test an additional booster dose of its […] Continue reading -> Cheaper To Fund Global Vaccines Than Suffer Economic Pandemic Fallout, Finds Study 25/01/2021 Kerry Cullinan Wealthy countries that pursue ‘vaccine nationalism’ when their trading partners don’t have access to the COVID-19 vaccine will pay a far higher economic price than if they invest in ensuring all countries have access to vaccines, according to a comprehensive economic modelling study released today by the World Health Organization (WHO). The study, commissioned by […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Important Advances in HIV Prevention Unveiled: New PrEP Formulas & Broadly Neutralizing Antibodies 27/01/2021 Paul Adepoju & Svĕt Lustig Vijay While global attention has fixated on the coronavirus, the forty-year long fight against HIV, which has claimed 33 million lives, is seeing new breakthroughs in preventive tools. New discoveries of “broadly neutralizing antibodies” as well as novel regimens of pre-exposure prophylaxis (PrEP), could strengthen the world’s toolbox to prevent the disease, announced the International AIDS […] Continue reading -> European Countries Start Recommending High-Filtration Masks – Over ‘Artisanal’ Cloth Variants 27/01/2021 Madeleine Hoecklin In the midst of the spread of new SARS-CoV2 virus variants, several European countries have updated their guidance and regulations on masks, to recommend the use of high-filtration medical-grade masks over fabric ones in confined settings. France’s health advisory council (Haute Conseil de la Santé Publique) issued new recommendations last week, warning against the wearing […] Continue reading -> Low-Income Countries Can Expect Higher Mortality From ‘Collateral Damage’ Than COVID-19, Global Fund Head Predicts 26/01/2021 J Hacker While very low-income countries have experienced relatively low mortality rates from COVID-19, they can expect higher mortality caused by the knock-on effects of the pandemic on their fragile health systems, according to the Executive Director of the Global Fund to Fight AIDS, TB and Malaria. Since the pandemic first overwhelmed health systems in early 2020, […] Continue reading -> Moderna’s COVID-19 Vaccine ‘Safe’ For Most People WHO Experts Say – But No Recommendation For Pregnant Women Or Children 26/01/2021 J Hacker The Moderna COVID-19 vaccine is safe for most people including those with a wide range of underlying medical conditions, according to the World Health Organization’s Strategic Advisory Group of Experts (SAGE) on immunizations. However, the vaccine is not recommended for pregnant women or children as it has not been tested on these groups, according to […] Continue reading -> COVAX Planning Per-Dose Vaccine Levy To Fund Compensation Scheme 26/01/2021 Kerry Cullinan The global COVID-19 vaccine access platform, COVAX, plans to impose a US 10-cent levy on each vaccine dose to fund a compensation scheme for people who suffer from severe adverse reactions to any of the vaccines it supplies. The “no-fault” compensation fund is crucial for countries who join COVAX, as one of the conditions of […] Continue reading -> Member States Raise Concerns About Sustainability Of Funding For Polio & Antimicrobial Resistance Efforts 26/01/2021 Madeleine Hoecklin COVID-19 has led to the suspension of polio campaigns in more than 30 countries, and has underscored the importance of the mission to eradicate it, tackle antimicrobial resistance, and ensure the timely sharing of pathogens, said WHO member states at Monday’s Executive Board session. Throughout the morning and afternoon sessions, member states reviewed and discussed […] Continue reading -> Interview with Björn Kümmel, Vice Chair, WHO Executive Board 26/01/2021 Priti Patnaik Discussions on WHO’s state of financing were addressed by member states during the on-going Executive Board meeting. As we reported last week, WHO is keen on defining independence and sustainability of its financing to be better prepared to address emergencies in the future. We spoke to Björn Kümmel, Deputy Head of Unit, Global Health, German Federal Ministry […] Continue reading -> UK COVID-19 Variant: US Official ‘Convinced’ Of Increased Mortality Despite ‘Uncertain’ Evidence 25/01/2021 J Hacker Michael Osterholm – a leading member of the United States President’s coronavirus transition team – has said he is “convinced” by data indicating the UK COVID-19 variant is more deadly, even as United Kingdom officials downplay the limited and “uncertain” evidence. Meanwhile, Moderna announced today that it will “test an additional booster dose of its […] Continue reading -> Cheaper To Fund Global Vaccines Than Suffer Economic Pandemic Fallout, Finds Study 25/01/2021 Kerry Cullinan Wealthy countries that pursue ‘vaccine nationalism’ when their trading partners don’t have access to the COVID-19 vaccine will pay a far higher economic price than if they invest in ensuring all countries have access to vaccines, according to a comprehensive economic modelling study released today by the World Health Organization (WHO). The study, commissioned by […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
European Countries Start Recommending High-Filtration Masks – Over ‘Artisanal’ Cloth Variants 27/01/2021 Madeleine Hoecklin In the midst of the spread of new SARS-CoV2 virus variants, several European countries have updated their guidance and regulations on masks, to recommend the use of high-filtration medical-grade masks over fabric ones in confined settings. France’s health advisory council (Haute Conseil de la Santé Publique) issued new recommendations last week, warning against the wearing […] Continue reading -> Low-Income Countries Can Expect Higher Mortality From ‘Collateral Damage’ Than COVID-19, Global Fund Head Predicts 26/01/2021 J Hacker While very low-income countries have experienced relatively low mortality rates from COVID-19, they can expect higher mortality caused by the knock-on effects of the pandemic on their fragile health systems, according to the Executive Director of the Global Fund to Fight AIDS, TB and Malaria. Since the pandemic first overwhelmed health systems in early 2020, […] Continue reading -> Moderna’s COVID-19 Vaccine ‘Safe’ For Most People WHO Experts Say – But No Recommendation For Pregnant Women Or Children 26/01/2021 J Hacker The Moderna COVID-19 vaccine is safe for most people including those with a wide range of underlying medical conditions, according to the World Health Organization’s Strategic Advisory Group of Experts (SAGE) on immunizations. However, the vaccine is not recommended for pregnant women or children as it has not been tested on these groups, according to […] Continue reading -> COVAX Planning Per-Dose Vaccine Levy To Fund Compensation Scheme 26/01/2021 Kerry Cullinan The global COVID-19 vaccine access platform, COVAX, plans to impose a US 10-cent levy on each vaccine dose to fund a compensation scheme for people who suffer from severe adverse reactions to any of the vaccines it supplies. The “no-fault” compensation fund is crucial for countries who join COVAX, as one of the conditions of […] Continue reading -> Member States Raise Concerns About Sustainability Of Funding For Polio & Antimicrobial Resistance Efforts 26/01/2021 Madeleine Hoecklin COVID-19 has led to the suspension of polio campaigns in more than 30 countries, and has underscored the importance of the mission to eradicate it, tackle antimicrobial resistance, and ensure the timely sharing of pathogens, said WHO member states at Monday’s Executive Board session. Throughout the morning and afternoon sessions, member states reviewed and discussed […] Continue reading -> Interview with Björn Kümmel, Vice Chair, WHO Executive Board 26/01/2021 Priti Patnaik Discussions on WHO’s state of financing were addressed by member states during the on-going Executive Board meeting. As we reported last week, WHO is keen on defining independence and sustainability of its financing to be better prepared to address emergencies in the future. We spoke to Björn Kümmel, Deputy Head of Unit, Global Health, German Federal Ministry […] Continue reading -> UK COVID-19 Variant: US Official ‘Convinced’ Of Increased Mortality Despite ‘Uncertain’ Evidence 25/01/2021 J Hacker Michael Osterholm – a leading member of the United States President’s coronavirus transition team – has said he is “convinced” by data indicating the UK COVID-19 variant is more deadly, even as United Kingdom officials downplay the limited and “uncertain” evidence. Meanwhile, Moderna announced today that it will “test an additional booster dose of its […] Continue reading -> Cheaper To Fund Global Vaccines Than Suffer Economic Pandemic Fallout, Finds Study 25/01/2021 Kerry Cullinan Wealthy countries that pursue ‘vaccine nationalism’ when their trading partners don’t have access to the COVID-19 vaccine will pay a far higher economic price than if they invest in ensuring all countries have access to vaccines, according to a comprehensive economic modelling study released today by the World Health Organization (WHO). The study, commissioned by […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Low-Income Countries Can Expect Higher Mortality From ‘Collateral Damage’ Than COVID-19, Global Fund Head Predicts 26/01/2021 J Hacker While very low-income countries have experienced relatively low mortality rates from COVID-19, they can expect higher mortality caused by the knock-on effects of the pandemic on their fragile health systems, according to the Executive Director of the Global Fund to Fight AIDS, TB and Malaria. Since the pandemic first overwhelmed health systems in early 2020, […] Continue reading -> Moderna’s COVID-19 Vaccine ‘Safe’ For Most People WHO Experts Say – But No Recommendation For Pregnant Women Or Children 26/01/2021 J Hacker The Moderna COVID-19 vaccine is safe for most people including those with a wide range of underlying medical conditions, according to the World Health Organization’s Strategic Advisory Group of Experts (SAGE) on immunizations. However, the vaccine is not recommended for pregnant women or children as it has not been tested on these groups, according to […] Continue reading -> COVAX Planning Per-Dose Vaccine Levy To Fund Compensation Scheme 26/01/2021 Kerry Cullinan The global COVID-19 vaccine access platform, COVAX, plans to impose a US 10-cent levy on each vaccine dose to fund a compensation scheme for people who suffer from severe adverse reactions to any of the vaccines it supplies. The “no-fault” compensation fund is crucial for countries who join COVAX, as one of the conditions of […] Continue reading -> Member States Raise Concerns About Sustainability Of Funding For Polio & Antimicrobial Resistance Efforts 26/01/2021 Madeleine Hoecklin COVID-19 has led to the suspension of polio campaigns in more than 30 countries, and has underscored the importance of the mission to eradicate it, tackle antimicrobial resistance, and ensure the timely sharing of pathogens, said WHO member states at Monday’s Executive Board session. Throughout the morning and afternoon sessions, member states reviewed and discussed […] Continue reading -> Interview with Björn Kümmel, Vice Chair, WHO Executive Board 26/01/2021 Priti Patnaik Discussions on WHO’s state of financing were addressed by member states during the on-going Executive Board meeting. As we reported last week, WHO is keen on defining independence and sustainability of its financing to be better prepared to address emergencies in the future. We spoke to Björn Kümmel, Deputy Head of Unit, Global Health, German Federal Ministry […] Continue reading -> UK COVID-19 Variant: US Official ‘Convinced’ Of Increased Mortality Despite ‘Uncertain’ Evidence 25/01/2021 J Hacker Michael Osterholm – a leading member of the United States President’s coronavirus transition team – has said he is “convinced” by data indicating the UK COVID-19 variant is more deadly, even as United Kingdom officials downplay the limited and “uncertain” evidence. Meanwhile, Moderna announced today that it will “test an additional booster dose of its […] Continue reading -> Cheaper To Fund Global Vaccines Than Suffer Economic Pandemic Fallout, Finds Study 25/01/2021 Kerry Cullinan Wealthy countries that pursue ‘vaccine nationalism’ when their trading partners don’t have access to the COVID-19 vaccine will pay a far higher economic price than if they invest in ensuring all countries have access to vaccines, according to a comprehensive economic modelling study released today by the World Health Organization (WHO). The study, commissioned by […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Moderna’s COVID-19 Vaccine ‘Safe’ For Most People WHO Experts Say – But No Recommendation For Pregnant Women Or Children 26/01/2021 J Hacker The Moderna COVID-19 vaccine is safe for most people including those with a wide range of underlying medical conditions, according to the World Health Organization’s Strategic Advisory Group of Experts (SAGE) on immunizations. However, the vaccine is not recommended for pregnant women or children as it has not been tested on these groups, according to […] Continue reading -> COVAX Planning Per-Dose Vaccine Levy To Fund Compensation Scheme 26/01/2021 Kerry Cullinan The global COVID-19 vaccine access platform, COVAX, plans to impose a US 10-cent levy on each vaccine dose to fund a compensation scheme for people who suffer from severe adverse reactions to any of the vaccines it supplies. The “no-fault” compensation fund is crucial for countries who join COVAX, as one of the conditions of […] Continue reading -> Member States Raise Concerns About Sustainability Of Funding For Polio & Antimicrobial Resistance Efforts 26/01/2021 Madeleine Hoecklin COVID-19 has led to the suspension of polio campaigns in more than 30 countries, and has underscored the importance of the mission to eradicate it, tackle antimicrobial resistance, and ensure the timely sharing of pathogens, said WHO member states at Monday’s Executive Board session. Throughout the morning and afternoon sessions, member states reviewed and discussed […] Continue reading -> Interview with Björn Kümmel, Vice Chair, WHO Executive Board 26/01/2021 Priti Patnaik Discussions on WHO’s state of financing were addressed by member states during the on-going Executive Board meeting. As we reported last week, WHO is keen on defining independence and sustainability of its financing to be better prepared to address emergencies in the future. We spoke to Björn Kümmel, Deputy Head of Unit, Global Health, German Federal Ministry […] Continue reading -> UK COVID-19 Variant: US Official ‘Convinced’ Of Increased Mortality Despite ‘Uncertain’ Evidence 25/01/2021 J Hacker Michael Osterholm – a leading member of the United States President’s coronavirus transition team – has said he is “convinced” by data indicating the UK COVID-19 variant is more deadly, even as United Kingdom officials downplay the limited and “uncertain” evidence. Meanwhile, Moderna announced today that it will “test an additional booster dose of its […] Continue reading -> Cheaper To Fund Global Vaccines Than Suffer Economic Pandemic Fallout, Finds Study 25/01/2021 Kerry Cullinan Wealthy countries that pursue ‘vaccine nationalism’ when their trading partners don’t have access to the COVID-19 vaccine will pay a far higher economic price than if they invest in ensuring all countries have access to vaccines, according to a comprehensive economic modelling study released today by the World Health Organization (WHO). The study, commissioned by […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
COVAX Planning Per-Dose Vaccine Levy To Fund Compensation Scheme 26/01/2021 Kerry Cullinan The global COVID-19 vaccine access platform, COVAX, plans to impose a US 10-cent levy on each vaccine dose to fund a compensation scheme for people who suffer from severe adverse reactions to any of the vaccines it supplies. The “no-fault” compensation fund is crucial for countries who join COVAX, as one of the conditions of […] Continue reading -> Member States Raise Concerns About Sustainability Of Funding For Polio & Antimicrobial Resistance Efforts 26/01/2021 Madeleine Hoecklin COVID-19 has led to the suspension of polio campaigns in more than 30 countries, and has underscored the importance of the mission to eradicate it, tackle antimicrobial resistance, and ensure the timely sharing of pathogens, said WHO member states at Monday’s Executive Board session. Throughout the morning and afternoon sessions, member states reviewed and discussed […] Continue reading -> Interview with Björn Kümmel, Vice Chair, WHO Executive Board 26/01/2021 Priti Patnaik Discussions on WHO’s state of financing were addressed by member states during the on-going Executive Board meeting. As we reported last week, WHO is keen on defining independence and sustainability of its financing to be better prepared to address emergencies in the future. We spoke to Björn Kümmel, Deputy Head of Unit, Global Health, German Federal Ministry […] Continue reading -> UK COVID-19 Variant: US Official ‘Convinced’ Of Increased Mortality Despite ‘Uncertain’ Evidence 25/01/2021 J Hacker Michael Osterholm – a leading member of the United States President’s coronavirus transition team – has said he is “convinced” by data indicating the UK COVID-19 variant is more deadly, even as United Kingdom officials downplay the limited and “uncertain” evidence. Meanwhile, Moderna announced today that it will “test an additional booster dose of its […] Continue reading -> Cheaper To Fund Global Vaccines Than Suffer Economic Pandemic Fallout, Finds Study 25/01/2021 Kerry Cullinan Wealthy countries that pursue ‘vaccine nationalism’ when their trading partners don’t have access to the COVID-19 vaccine will pay a far higher economic price than if they invest in ensuring all countries have access to vaccines, according to a comprehensive economic modelling study released today by the World Health Organization (WHO). The study, commissioned by […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Member States Raise Concerns About Sustainability Of Funding For Polio & Antimicrobial Resistance Efforts 26/01/2021 Madeleine Hoecklin COVID-19 has led to the suspension of polio campaigns in more than 30 countries, and has underscored the importance of the mission to eradicate it, tackle antimicrobial resistance, and ensure the timely sharing of pathogens, said WHO member states at Monday’s Executive Board session. Throughout the morning and afternoon sessions, member states reviewed and discussed […] Continue reading -> Interview with Björn Kümmel, Vice Chair, WHO Executive Board 26/01/2021 Priti Patnaik Discussions on WHO’s state of financing were addressed by member states during the on-going Executive Board meeting. As we reported last week, WHO is keen on defining independence and sustainability of its financing to be better prepared to address emergencies in the future. We spoke to Björn Kümmel, Deputy Head of Unit, Global Health, German Federal Ministry […] Continue reading -> UK COVID-19 Variant: US Official ‘Convinced’ Of Increased Mortality Despite ‘Uncertain’ Evidence 25/01/2021 J Hacker Michael Osterholm – a leading member of the United States President’s coronavirus transition team – has said he is “convinced” by data indicating the UK COVID-19 variant is more deadly, even as United Kingdom officials downplay the limited and “uncertain” evidence. Meanwhile, Moderna announced today that it will “test an additional booster dose of its […] Continue reading -> Cheaper To Fund Global Vaccines Than Suffer Economic Pandemic Fallout, Finds Study 25/01/2021 Kerry Cullinan Wealthy countries that pursue ‘vaccine nationalism’ when their trading partners don’t have access to the COVID-19 vaccine will pay a far higher economic price than if they invest in ensuring all countries have access to vaccines, according to a comprehensive economic modelling study released today by the World Health Organization (WHO). The study, commissioned by […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Interview with Björn Kümmel, Vice Chair, WHO Executive Board 26/01/2021 Priti Patnaik Discussions on WHO’s state of financing were addressed by member states during the on-going Executive Board meeting. As we reported last week, WHO is keen on defining independence and sustainability of its financing to be better prepared to address emergencies in the future. We spoke to Björn Kümmel, Deputy Head of Unit, Global Health, German Federal Ministry […] Continue reading -> UK COVID-19 Variant: US Official ‘Convinced’ Of Increased Mortality Despite ‘Uncertain’ Evidence 25/01/2021 J Hacker Michael Osterholm – a leading member of the United States President’s coronavirus transition team – has said he is “convinced” by data indicating the UK COVID-19 variant is more deadly, even as United Kingdom officials downplay the limited and “uncertain” evidence. Meanwhile, Moderna announced today that it will “test an additional booster dose of its […] Continue reading -> Cheaper To Fund Global Vaccines Than Suffer Economic Pandemic Fallout, Finds Study 25/01/2021 Kerry Cullinan Wealthy countries that pursue ‘vaccine nationalism’ when their trading partners don’t have access to the COVID-19 vaccine will pay a far higher economic price than if they invest in ensuring all countries have access to vaccines, according to a comprehensive economic modelling study released today by the World Health Organization (WHO). The study, commissioned by […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
UK COVID-19 Variant: US Official ‘Convinced’ Of Increased Mortality Despite ‘Uncertain’ Evidence 25/01/2021 J Hacker Michael Osterholm – a leading member of the United States President’s coronavirus transition team – has said he is “convinced” by data indicating the UK COVID-19 variant is more deadly, even as United Kingdom officials downplay the limited and “uncertain” evidence. Meanwhile, Moderna announced today that it will “test an additional booster dose of its […] Continue reading -> Cheaper To Fund Global Vaccines Than Suffer Economic Pandemic Fallout, Finds Study 25/01/2021 Kerry Cullinan Wealthy countries that pursue ‘vaccine nationalism’ when their trading partners don’t have access to the COVID-19 vaccine will pay a far higher economic price than if they invest in ensuring all countries have access to vaccines, according to a comprehensive economic modelling study released today by the World Health Organization (WHO). The study, commissioned by […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Cheaper To Fund Global Vaccines Than Suffer Economic Pandemic Fallout, Finds Study 25/01/2021 Kerry Cullinan Wealthy countries that pursue ‘vaccine nationalism’ when their trading partners don’t have access to the COVID-19 vaccine will pay a far higher economic price than if they invest in ensuring all countries have access to vaccines, according to a comprehensive economic modelling study released today by the World Health Organization (WHO). The study, commissioned by […] Continue reading -> Posts navigation Older postsNewer posts